FDA surveillance of whistleblowers, part 3

The Food and Drug Administration secretly monitored the personal e-mail of six employees after they warned Congress and the White House that the agency was approving medical devices that posed unacceptable risks to patients, according to a lawsuit filed this week. These selected e-mails and memos were compiled by Kohn, Kohn and Colapinto, the law firm representing the whistleblowers, on behalf of the National Whistleblower Center as part of the lawsuit. View the set of documents.